http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-002263-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J53-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J71-0005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J53-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J71-00 |
| filingDate | 1995-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8469e8dd0f9dc32ee711ddff7a27bece http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fde51a25dfb1f36af02a421550bce10e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b47dea2a4cd8803acd8e0a3552b181e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49a7c62ea49d3994425097aa082531d5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4fcc653857f5dbc70058d0022b4fb59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6ce3f81362f3e25a7aaa917d4256150 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14f526324fa921f9c53886158dcc4d47 |
| publicationDate | 1998-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AR-002263-A1 |
| titleOfInvention | DERIVATIVES OF 19-NOR-PROGESTERONE BRIDGED IN C2-14Ó, 17Ó, INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS THAT CONTAIN THEM |
| abstract | The invention describes the C2-14O, 17O bridged 19-nor-progesterone derivatives with the general formula (I), wherein R3 represents a deoxygen atom, the hydroximine group or two hydrogen atoms; R6 represents a hydrogen, fluorine, chlorine or bromine atom or a C1-C4 alkyl radical in position Ó or ß, where R6 and R7 represent hydrogen atoms, or else R6 represents a hydrogen, fluorine, chlorine or bromine atom, or a C1-C4 alkyl radical, where then R6 and R7 represent an additional common bond, R7 represents a C1-C4 alkyl radical in the Ó or ß position, where R6 and R6 represent hydrogen atoms, or R6 and R7 together represent a methylene group in position Ó or ß and R6 a hydrogen atom, or R6 and R6 together, represent an ethylene omethylene group, and R7 represents a hydrogen atom, R9 and R10 individually represent a hydrogen atom or together a bond, R11 and R12 individually represent a hydrogen atom or together a bond, R13 represents a methyl or ethyl group, R15 represents a hydrogen atom or a C1-C3 alkyl radical; R16 and R16 independently represent a hydrogen atom, a C1-C3 alkyl radical or a C2-C4 alkenyl radical, or, together, a C1-C3 alkyldid group, R15 and R16 together represent a bond and R16 a hydrogen atom or a C1-C3 alkyl moiety; R15 and R16 together represent a ring with the partial formula (II), where n = 1 and 2 and X represent a methylene group or an oxygen atom, as well as R16 a hydrogen atom; R171 represents a hydrogen atom or a C1-C3 alkyl moiety; R172 represents a hydrogen atom, a C1-C3 alkyl radical or a C2-C4 alkylene radical; R171 and R172 individually represent a hydrogen atom or together, form a bond; R21 represents a hydrogen atom or a C1-C3 alkyl moiety; R21 |
| priorityDate | 1994-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 41.